Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Tudor CS, Dawson CW, Eckhardt J, Niedobitek G, Büttner AC, Seliger B, Hartmann A, Buettner M.

Br J Cancer. 2012 Jun 5;106(12):1980-8. doi: 10.1038/bjc.2012.197. Epub 2012 May 15.

2.

[Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].

Liu QY, Han AJ, You SY, Dong Y, Yang QX, Wu JH, Li MF.

Ai Zheng. 2008 Oct;27(10):1070-6. Chinese.

PMID:
18851787
3.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217
4.
5.

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, Shi Y, Yi W, Cao Y.

Mol Cancer. 2009 Oct 27;8:92. doi: 10.1186/1476-4598-8-92.

6.

Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.

Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li LL, Luo W, Tang M, Cao Y.

Int J Mol Med. 2008 Feb;21(2):153-62.

PMID:
18204781
7.

Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.

Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang M, Chen L, Yang L, Tao Y, Jiang Y, Li J, Yi B, Li B, Fan S, You S, Deng X, Hu F, Feng L, Bode AM, Dong Z, Sun LQ, Cao Y.

Oncogene. 2014 Sep 11;33(37):4568-78. doi: 10.1038/onc.2014.32. Epub 2014 Mar 24.

9.
10.

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.

Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquère S, Nishi N, Hirashima M, Middeldorp J, Busson P.

BMC Cancer. 2006 Dec 8;6:283.

11.

Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.

Chen J, Hu CF, Hou JH, Shao Q, Yan LX, Zhu XF, Zeng YX, Shao JY.

J Transl Med. 2010 Mar 26;8:30. doi: 10.1186/1479-5876-8-30.

12.
13.

Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

Stewart S, Dawson CW, Takada K, Curnow J, Moody CA, Sixbey JW, Young LS.

Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15730-5. Epub 2004 Oct 21.

14.
15.

Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.

Guo L, Tang M, Yang L, Xiao L, Bode AM, Li L, Dong Z, Cao Y.

Int J Mol Med. 2012 Apr;29(4):574-80. doi: 10.3892/ijmm.2012.889. Epub 2012 Jan 17.

16.

EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.

Liu H, Duan Z, Zheng H, Hu D, Li M, Tao Y, Bode AM, Dong Z, Cao Y.

PLoS One. 2012;7(3):e32624. doi: 10.1371/journal.pone.0032624. Epub 2012 Mar 1.

17.

Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function.

Pai S, O'Sullivan B, Abdul-Jabbar I, Peng J, Connoly G, Khanna R, Thomas R.

Immunol Cell Biol. 2007 Jul;85(5):370-7. Epub 2007 Mar 20.

PMID:
17372611
19.

Expression of miRNA-146a in nasopharyngeal carcinoma is upregulated by Epstein-Barr virus latent membrane protein 1.

Zhao Y, Chen X, Jing M, Du H, Zeng Y.

Oncol Rep. 2012 Oct;28(4):1237-42. doi: 10.3892/or.2012.1933. Epub 2012 Jul 25.

PMID:
22843060
20.

Supplemental Content

Support Center